#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marfan's syndrome Inborn error of metabolism Cutaneous T-cell lymphoma recurrent Glomerulonephritis rapidly progressive Renal disorder Adult T-cell lymphoma/leukaemia refractory Primary amyloidosis Autoimmune haemolytic anaemia Ventricular tachycardia Epstein-Barr virus infection B precursor type acute leukaemia Staphylococcal infection Mitochondrial myopathy Astrocytoma malignant Pericarditis More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Treatment Paroxysmal nocturnal haemoglobinuria – Basic Information Netherton’s syndrome Metachromatic leukodystrophy – Basic Information Lennox-Gastaut syndrome – Diagnostics Ehlers-Danlos syndrome Vascular malformation – Basic Information Sjogren’s syndrome Crigler-Najjar syndrome – Life with Disease Systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thiamine Nitrate VGA039 Clofutriben IDOR-1117-2520C Panitumumab Flutemetamol (18F) Odm-212 Regn5668 Mycophenolate Sodium Suxamethonium Chloride Ly3437943 Sodium Mb-Cart20.1 Carbetocin Clofazimine Citric Acid Bepranemab Lolium Perenne Pollen Extract ALPROSTADIL Canakinumab Vortioxetine Hydrobromide More therapies…

    Learn about Your Condition

    Spina bifida Heart transplant Colon cancer metastatic B-cell lymphoma High-grade B-cell lymphoma Peripheral ischaemia Hodgkin's disease recurrent Decreased appetite Mucopolysaccharidosis III Peripheral artery angioplasty Toxic epidermal necrolysis Muscle spasticity Fibromyalgia Delirium Haemorrhage intracranial More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Vaesterviks Sjukhus Region Kalmar Laen

Vaesterviks Sjukhus Region Kalmar Laen

Ostra Kyrkogatan 48, Vastervik, 593 33, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Saline
    • Vancomycin
    Denmark Sweden

  • Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Misoprostol
    Sweden

  • Study on the Effects of Tinzaparin on Biomarkers in Advanced Ovarian Cancer Patients Receiving Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage III
    • Ovarian cancer stage IV
    • Ovarian cancer
    Investigated Drugs:
    • Tinzaparin Sodium
    Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!